Advertisement

Topics

Latest "TELOON SOFT STRATEGY LTD" News Stories

23:06 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "TELOON SOFT STRATEGY LTD" found in our extensive news archives from over 250 global news sources.

More Information about TELOON SOFT STRATEGY LTD on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about TELOON SOFT STRATEGY LTD for you to read. Along with our medical data and news we also list TELOON SOFT STRATEGY LTD Clinical Trials, which are updated daily. BioPortfolio also has a large database of TELOON SOFT STRATEGY LTD Companies for you to search.

Showing "TELOON SOFT STRATEGY" News Articles 1–25 of 14,000+

Tuesday 18th December 2018

Crown Bioscience Inc 6554 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCrown Bioscience Inc Crown Bioscience is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, oncology services, and metabolic disease services, among others. Crown Bioscience provides its preclinical...


Jiangsu Jumpcan Pharmaceutical Group Co Ltd 600566 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryJiangsu Jumpcan Pharmaceutical Group Co Ltd Jiangsu Jumpcan Pharma is a developer, manufacturer and distributor of Chinese traditional medicine, Western medicine, daily use chemicals and healthcare products. The company offers its products in various therapeutic segments such as detoxification, digestive system, pediatric, respiratory system, nervous system, antiinfection, cardiovascular, n...

Helsinn Healthcare SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryHelsinn Healthcare SA Helsinn Healthcare, a subsidiary of Helsinn Holding SA is a cancer care company that offers oncology products and therapies. The company offers products in therapeutic areas of pain and inflammation, cancer care and gastroenterology. Its products comprise Aloxi, Gelclair, Akynzeo, Nimesulide, KleanPrep and laxaclear. The company offers research and development programs...


Anji Pharmaceuticals Licenses Regional Rights to a Clinical Asset from Global Pharma

Anji Pharmaceuticals, Inc. (“Anji” or “the Company”) announced today it has licensed pradigastat, an inhibitor of acyl coA: diacylglycerol acyl transferase (DGAT1), from Novartis (NYSE: NVS). Pradigastat is a well-characterized molecule which has progressed to Phase 3 clinical testing. Anji has secured rights to pursue new indications for pradigast...

Alfa Wassermann SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryAlfa Wassermann SpA Alfa Wassermann, a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company offers self meditation products for sore throat, headaches, and muscle and joint pain treatments. It als...

Canadian Cancer Trials Group Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryCanadian Cancer Trials Group CCTG, is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It provides services for cancer therapy, supportive care and prevention. CCTG offers clinical trials for prod...

Martindale Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryMartindale Pharmaceuticals Ltd Martindale, a subsidiary of Cardinal Health Inc is a pharmaceutical company that offers formulations. The company provides hospitalinitiated medicines in emergency medicine and differentiated products in complex neurological conditions,opioid addiction and paediatric cardiology. It focuses on emergency care drugs, hospital initiated medicines, opioid addiction...

New RNA sequencing strategy to study gut microbiome activity

Researchers have developed a high-throughput RNA sequencing strategy to study the activity of the gut microbiome. The new tools analyse transfer RNA (tRNA), a molecular Rosetta Stone that translates the genetic information encoded in DNA into proteins that perform basic biological functions. Developing a clear picture of tRNA dynamics will allow scientists to understand the activity of naturally ...

Cellular Dynamics International Inc Medical Equipment Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryCellular Dynamics International Inc CDI, a subsidiary of Fujifilm Holdings Corp is a biotechnology company that develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The company's products include icell cardiomyocytes, icell endothelial cells, icell hepatocytes, icell neurons, icell prototypes and mycell products. It also offers Mycell p...

UPMC chief innovation officer will head to Atrium Health

Rasu Shrestha, UPMC’s chief innov

Scynexis Inc SCYX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryScynexis Inc Scynexis is a pharmaceutical company that discovers, develops and commercializes novel antiinfective for various therapeutic needs. The company provides pipeline products such as SCY078, is used for invasive fungal infections; SCY635, is used for the treatment of Hepatitis C HCV; SCYX7158, is used for sleeping sickness; SCY641, is for human health, among others. Its SCY078 is a...

Rasu Shrestha Leaving UPMC to Join Atrium Health as Chief Strategy Officer

Heather Landi, Associate EditorIndustry thought leader Rasu Shrestha, M.D., formerly Chief Innovation Officer at the vast 40-hospital UPMC, is leaving Pittsburgh to join Charlotte, North Carolina-based Atrium Health has the new executive vice president and chief strategy officer.

Anavex Life Sciences Corp AVXL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAnavex Life Sciences Corp Anavex is a clinicalstage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system CNS diseases, pain and various types of cancer. The company's target indications include Alzheimer's disease, Parkinson's disease, Rett syndrome, epilepsy, neu...

Cyprotex Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryCyprotex Ltd Cyprotex, a subsidiary of Evotec AG is a provider of ADMETox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company's core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including propriet...

Definiens AG Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryDefiniens AG Definiens, a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include consulting and planning services, image analysis solution services, integration and deployment services and...

Editas Medicine Inc EDIT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryEditas Medicine Inc Editas Medicine formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its inlicensed clustered regularly interspaced short palindromic repeats CRISPR technology. The company's preclinical pipeline spans investigational candidates fo...

Leadiant Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryLeadiant Biosciences Inc Leadiant Biosciences, formerly SigmaTau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matulane and revcovi, among others. It also offers services including patient support, discovery and develop...

Recipharm AB RECI B Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryRecipharm AB Recipharm is a contract development and manufacturing organization CDMO that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semisolids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm's dev...

First-Ever Human Health and Animal Health Drug Development Collaboration to Prevent Cancer Recurrence

Ethos Veterinary Health and Vuja De Sciences to utilize novel cellular assays of cancer metastasis and integration of pet dogs with cancer to empower innovative metastasis-focused drug development collaboration. WOBURN, Mass. and HOBOKEN, N.J. (PRWEB) December 18, 2018 Ethos Veterinary Health (“Ethos”) and Vuja De Sciences (“Vuja De”) have entered into a Memorandum of Understanding to ide...

Memorial Sloan Kettering Cancer Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryMemorial Sloan Kettering Cancer Center MSKCC is a healthcare service provider that offers cancer treatment, cancer research and cancer education programs. The center conducts research in therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeutics and drug development, cell biology, cell cycle regulation, cell death, cell signaling, immunology, genet...

University of Washington Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryUniversity of Washington UoW is an educational institution that provides undergraduate, postgraduate and master's degrees. The university provides courses in the areas of accounting, aeronautics, applied mathematics, bioengineering, business, social sciences, science, law, medicine, and public affairs. It also offers services in nursing, health services, astronomy, computer science, molecul...

QRxPharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryQRxPharma Ltd QRxPharma develops and commercializes treatments for pain management and abuse prevention products. The company's product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR Q8003, an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV Q8012, an intravenous...

New Sequencing Techniques Could Shed Light on Gut Microbiomes

ArticleA research team has created a new computational high-throughput RNA sequencing strategy.

Cesca Therapeutics Inc KOOL Medical Equipment Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryCesca Therapeutics Inc Cesca researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cellbased therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The compan...

Justin Mennen Named Rite Aid Senior Vice President and Chief Information Officer

Rite Aid Corporation (NYSE: RAD) announced today that Justin Mennen, a seasoned technology and digital leader with more than 20 years of technology leadership experience, has been named Rite Aid’s senior vice president and chief information officer. In this position, Mennen will be responsible for all aspects of the company’s technology and in...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks